12 days ago
KARD
AnalystsDennis DingDennis Ding's Stock Forecasts
AnalystsDennis Ding
Sectors:
Analyst Ranking
Bottom 10%
#4848 out of 5334 analysts
Average Return
-7.63%
Win Rate
33%6 out of 18
Risk vs Reward
Poor
Good
Dennis Ding's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Indivior Pharmaceuticals IncINDV | +150.00% | $16.18 | $40.45 | 2025-07-22 - 2026-07-21 | Strong Buy |
Roivant Sciences LtdROIV | +132.01% | $15.09 | $35.01 | 2025-09-18 - 2026-07-24 | Strong Buy |
Cincor Pharma IncCINC | +52.26% | $19.00 | $28.93 | 2022-02-01 - 2023-01-31 | Strong Buy |
Crinetics Pharmaceuticals IncCRNX | +43.36% | $38.65 | $55.41 | 2025-01-22 - 2026-01-21 | Strong Buy |
Assembly Biosciences IncASMB | +25.89% | $19.43 | $24.46 | 2024-09-20 - 2025-09-19 | Strong Buy |
Dennis Ding Analyst Color
Get additional color on Dennis Ding's coverage of popular stocks
Dennis Ding's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kardigan IncKARD | 1 | Strong Buy | $40.00 | +92.86% | Initiates Coverage On | 12 days ago |
Crinetics Pharmaceuticals IncCRNX | 2 | Hold | $85.00 | +1.52% | Downgrades | 18 days ago |
Amphastar Pharmaceuticals IncAMPH | 1 | Hold | $22.00 | +17.52% | Downgrades | 3 months ago |
Olema Pharmaceuticals IncOLMA | 1 | Strong Buy | $40.00 | +241.88% | Assumes | 4 months ago |
Spyglass Pharma IncSGP | 1 | Strong Buy | $62.00 | +202.59% | Initiates Coverage On | 5 months ago |
Amicus Therapeutics IncFOLD | 2 | Hold | $14.50 | +0.07% | Downgrades | 6 months ago |
Roivant Sciences LtdROIV | 2 | Strong Buy | $20.00 | -42.87% | Maintains | 10 months ago |
Mineralys Therapeutics IncMLYS | 2 | Hold | $26.00 | -2.66% | Maintains | a year ago |
Indivior Pharmaceuticals IncINDV | 1 | Strong Buy | $20.00 | N/A | Assumes | a year ago |
Inhibikase Therapeutics IncIKT | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Assembly Biosciences IncASMB | 1 | Strong Buy | $35.00 | N/A | Upgrades | 2 years ago |
Arbutus Biopharma CorpABUS | 2 | Strong Buy | $7.00 | N/A | Maintains | 2 years ago |
Recursion Pharmaceuticals IncRXRX | 1 | Hold | $6.00 | N/A | Maintains | 2 years ago |
Lyra Therapeutics IncLYRA | 1 | Hold | $25.00 | N/A | Downgrades | 2 years ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $216.00 | N/A | Reiterates | 3 years ago |
Corcept Therapeutics IncCORT | 1 | Hold | $22.00 | N/A | Downgrades | 3 years ago |
Newamsterdam Pharma Co NvNAMS | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Ngm Biopharmaceuticals IncNGM | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Cincor Pharma IncCINC | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Pardes Biosciences IncPRDS | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 5 years ago |
Sigilon Therapeutics IncSGTX | 2 | Hold | $52.00 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.